GKOS
Price
$83.65
Change
-$3.35 (-3.85%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
4.61B
24 days until earnings call
NTRA
Price
$133.82
Change
-$4.89 (-3.53%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
11.04B
31 days until earnings call
Ad is loading...

GKOS vs NTRA

Header iconGKOS vs NTRA Comparison
Open Charts GKOS vs NTRABanner chart's image
Glaukos
Price$83.65
Change-$3.35 (-3.85%)
Volume$6.03K
Capitalization4.61B
Natera
Price$133.82
Change-$4.89 (-3.53%)
Volume$33.05K
Capitalization11.04B
GKOS vs NTRA Comparison Chart
Loading...
GKOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GKOS vs. NTRA commentary
Apr 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GKOS is a Buy and NTRA is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 06, 2025
Stock price -- (GKOS: $87.00 vs. NTRA: $138.71)
Brand notoriety: GKOS and NTRA are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: GKOS: 216% vs. NTRA: 80%
Market capitalization -- GKOS: $4.61B vs. NTRA: $11.04B
GKOS [@Medical Specialties] is valued at $4.61B. NTRA’s [@Medical Specialties] market capitalization is $11.04B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GKOS’s FA Score shows that 0 FA rating(s) are green whileNTRA’s FA Score has 0 green FA rating(s).

  • GKOS’s FA Score: 0 green, 5 red.
  • NTRA’s FA Score: 0 green, 5 red.
According to our system of comparison, both GKOS and NTRA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GKOS’s TA Score shows that 4 TA indicator(s) are bullish while NTRA’s TA Score has 5 bullish TA indicator(s).

  • GKOS’s TA Score: 4 bullish, 4 bearish.
  • NTRA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, NTRA is a better buy in the short-term than GKOS.

Price Growth

GKOS (@Medical Specialties) experienced а -16.04% price change this week, while NTRA (@Medical Specialties) price change was -6.47% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -5.93%. For the same industry, the average monthly price growth was -2.09%, and the average quarterly price growth was -1.65%.

Reported Earning Dates

GKOS is expected to report earnings on Apr 30, 2025.

NTRA is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Medical Specialties (-5.93% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTRA($11B) has a higher market cap than GKOS($4.61B). NTRA YTD gains are higher at: -12.375 vs. GKOS (-41.977). GKOS has higher annual earnings (EBITDA): -82.12M vs. NTRA (-397.8M). NTRA has more cash in the bank: 879M vs. GKOS (295M). GKOS has less debt than NTRA: GKOS (384M) vs NTRA (442M). NTRA has higher revenues than GKOS: NTRA (1.08B) vs GKOS (315M).
GKOSNTRAGKOS / NTRA
Capitalization4.61B11B42%
EBITDA-82.12M-397.8M21%
Gain YTD-41.977-12.375339%
P/E RatioN/AN/A-
Revenue315M1.08B29%
Total Cash295M879M34%
Total Debt384M442M87%
FUNDAMENTALS RATINGS
GKOS vs NTRA: Fundamental Ratings
GKOS
NTRA
OUTLOOK RATING
1..100
96
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
54
Fair valued
PROFIT vs RISK RATING
1..100
3934
SMR RATING
1..100
9594
PRICE GROWTH RATING
1..100
6551
P/E GROWTH RATING
1..100
54100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NTRA's Valuation (54) in the Biotechnology industry is somewhat better than the same rating for GKOS (93) in the Medical Specialties industry. This means that NTRA’s stock grew somewhat faster than GKOS’s over the last 12 months.

NTRA's Profit vs Risk Rating (34) in the Biotechnology industry is in the same range as GKOS (39) in the Medical Specialties industry. This means that NTRA’s stock grew similarly to GKOS’s over the last 12 months.

NTRA's SMR Rating (94) in the Biotechnology industry is in the same range as GKOS (95) in the Medical Specialties industry. This means that NTRA’s stock grew similarly to GKOS’s over the last 12 months.

NTRA's Price Growth Rating (51) in the Biotechnology industry is in the same range as GKOS (65) in the Medical Specialties industry. This means that NTRA’s stock grew similarly to GKOS’s over the last 12 months.

GKOS's P/E Growth Rating (54) in the Medical Specialties industry is somewhat better than the same rating for NTRA (100) in the Biotechnology industry. This means that GKOS’s stock grew somewhat faster than NTRA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GKOSNTRA
RSI
ODDS (%)
Bullish Trend 5 days ago
79%
Bullish Trend 5 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 5 days ago
86%
Momentum
ODDS (%)
Bearish Trend 5 days ago
60%
Bearish Trend 5 days ago
80%
MACD
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 5 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
67%
Bearish Trend 5 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
67%
Bearish Trend 5 days ago
77%
Advances
ODDS (%)
Bullish Trend 13 days ago
79%
Bullish Trend 12 days ago
82%
Declines
ODDS (%)
Bearish Trend 5 days ago
67%
Bearish Trend 5 days ago
79%
BollingerBands
ODDS (%)
N/A
Bullish Trend 5 days ago
85%
Aroon
ODDS (%)
Bearish Trend 5 days ago
73%
Bearish Trend 5 days ago
87%
View a ticker or compare two or three
Ad is loading...
GKOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X83102.830000617.109400
+0.75%
Bitcoin cryptocurrency
SPY536.70-27.82
-4.93%
SPDR® S&P 500® ETF Trust
TSLA267.28-15.48
-5.47%
Tesla
GME21.10-1.59
-7.01%
GameStop Corp
AAPL203.19-20.70
-9.25%
Apple

GKOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GKOS has been loosely correlated with ISRG. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if GKOS jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GKOS
1D Price
Change %
GKOS100%
-13.03%
ISRG - GKOS
45%
Loosely correlated
-2.45%
RDNT - GKOS
43%
Loosely correlated
-5.71%
NTRA - GKOS
42%
Loosely correlated
-3.14%
ICUI - GKOS
41%
Loosely correlated
+0.85%
AORT - GKOS
41%
Loosely correlated
-3.63%
More

NTRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTRA has been loosely correlated with ISRG. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if NTRA jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTRA
1D Price
Change %
NTRA100%
-3.14%
ISRG - NTRA
48%
Loosely correlated
-2.45%
RDNT - NTRA
43%
Loosely correlated
-5.71%
GH - NTRA
43%
Loosely correlated
-3.38%
VCYT - NTRA
43%
Loosely correlated
-5.51%
BSX - NTRA
43%
Loosely correlated
-1.55%
More